Neurocompute Narrative Velocity Map
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative
Velocity Map

Explore the Parkinson’s research intelligence diagram before entering the Neurocompute platform.

NC
Neurocompute
AI Parkinson’s Intelligence Terminal
NARRATIVE VELOCITY ENGINE

Neurocompute

AI-driven Parkinson’s research intelligence platform exploring emerging signals, forgotten papers, and therapeutic patterns across the biomedical literature universe.

Indexed Papers
1,516
AI Scored
984
Ranked Papers
998
Coverage
1.3%
RESEARCH INTELLIGENCE BOARD

Ranked Parkinson’s Papers

1516 results
LAST INGEST 2026-05-29 06:45 PM
AI Summary

This large randomized, double-blind, multicenter trial will test whether precision neuroimaging-guided continuous theta-burst stimulation targeting the left supplementary motor area improves motor symptoms in 290 Parkinson's patients versus sham, with primary outcome MDS-UPDRS III at day 8 and…

Why It Matters

A positive result would provide high-quality clinical evidence for a noninvasive, reproducible neuromodulation therapy as an adjunctive symptomatic treatment for PD motor deficits and support broader translational development of precision rTMS protocols.

E
Pathology and genetics in a global cohort of Parkinsonian Disorders.
PMID 41929290 Published: 2026-03-26 Ingested: 2026-04-28 08:58 PM medRxiv : the preprint server for health sciences
AI 60.0
Base 30.8
Rank 29.2
AI Summary

Large multicenter autopsy study of 3,353 donors quantifying clinicopathological concordance, showing ~10–20% misdiagnosis rates, 40% Alzheimer’s co-pathology in Lewy body disease, greater Lewy body burden in GBA1 carriers, and ancestry-related differences in pathological diagnoses independent of…

Why It Matters

By linking genetics (notably GBA1), pathology, and ancestry at scale, the study informs biomarker development and patient stratification for trials—improving therapeutic targeting and cohort selection even though it does not report new molecular interventions.

E
Brain-Only Versus GI-Only Synucleinopathy: A Comprehensive Autopsy Study With Both IHC and SAA.
PMID 41929295 Published: 2026-03-24 Ingested: 2026-04-28 08:58 PM medRxiv : the preprint server for health sciences
AI 60.0
Base 30.8
Rank 29.2
AI Summary

Autopsy study using immunohistochemistry and RT‑QuIC on brain and gastrointestinal samples from 178 subjects reports GI‑only alpha‑synuclein pathology is rare while brain‑only pathology is substantially more common, and the count of SAA‑positive GI sites correlates with motor and GI autonomic…

Why It Matters

This work refines the gut‑versus‑brain origin debate for synucleinopathy, validates RT‑QuIC SAA in GI tissue as a symptom‑linked biomarker useful for patient stratification, and suggests gut‑directed interventions may be relevant only to a minority—important for prioritizing therapeutic targets and…

E
Translating brain anatomy and disease from mouse to human in latent gene expression space.
PMID 42034047 Published: 2026-04-24 Ingested: 2026-04-28 08:58 PM EBioMedicine
AI 58.0
Base 30.8
Rank 29.2
AI Summary

The authors built a cross-species latent gene-expression space using a variational autoencoder trained on mouse spatial transcriptomics and embedded human orthologs to translate and predict human anatomical and disease-related brain changes from mouse models, validated for Alzheimer's and…

Why It Matters

This quantitative translation tool helps identify which mouse models and disease stages best recapitulate human Parkinson's expression changes, improving model selection and thereby enhancing the translational relevance of preclinical therapeutic discovery.

E
AI 58.0
Base 30.8
Rank 29.2
AI Summary

Encapsulation of CDNF in collagen hydrogels enabled sustained intracerebral delivery that improved motor behavior in a rodent PD model and dose-dependently altered brain N‑glycosylation, particularly core‑fucosylated glycans.

Why It Matters

Provides a translationally relevant biomaterial delivery approach for a neurotrophic therapy and links CDNF efficacy to reversible N‑glycome changes, suggesting both a mechanistic readout and potential biomarker for therapeutic development.

E
Moiety-specific mechanism of ATP's hydrotropic action on α-synuclein.
PMID 42027070 Published: 2026-04-24 Ingested: 2026-04-28 08:58 PM Physical chemistry chemical physics : PCCP
AI 56.0
Base 30.8
Rank 29.2
AI Summary

Using NMR and MD, the authors show that ATP's adenine and triphosphate moieties differentially bind α-synuclein—triphosphate forms strong contacts with N-terminal lysines that expand the protein while adenine makes weak multisite interactions—producing a concentration-dependent "hierarchical…

Why It Matters

Provides a concrete molecular mechanism linking ATP to α-synuclein conformational regulation, highlighting ATP-mimetic moieties and site-specific interactions as actionable starting points for anti-aggregation strategies relevant to Parkinson's disease, though cellular and in vivo validation are…

E
AI 56.0
Base 30.8
Rank 29.2
AI Summary

Targeted sequencing of 61 neurodegeneration genes in 186 Sicilian patients identified pathogenic/likely pathogenic variants in ~21% (diagnostic yield 16.7%), with GBA showing the highest number of pathogenic hits and broad phenotypic associations across AD, PD, FTD and parkinsonism.

Why It Matters

Highlights clinically actionable genetic stratification—particularly enrichment of GBA (lysosomal) variants—supporting patient selection, biomarker development, and translational relevance for GCase/lysosome-targeted Parkinson's therapeutics and diagnostics.

E
Janus kinase 2 regulates Nurr1 protein stability in dopaminergic neurons of the aging midbrain.
PMID 41929045 Published: 2026-03-23 Ingested: 2026-04-28 08:58 PM bioRxiv : the preprint server for biology
AI 56.0
Base 30.8
Rank 29.2
AI Summary

JAK2 is induced in aged midbrain dopaminergic neurons and physically interacts with Nurr1 to enhance its nuclear stability and transcriptional activity (independent of canonical JAK/STAT signaling), with constitutively active JAK2 V617F increasing Nurr1 protein and reducing oxidative-stress…

Why It Matters

This reveals a druggable, noncanonical regulator of Nurr1 stability that could be leveraged to boost dopaminergic neuron resilience in aging and Parkinson's disease, though oncogenic concerns around JAK2 activation and lack of in vivo therapeutic validation temper immediate translational potential.

E
Multimodal Image Guidance in Subthalamic Deep Brain Stimulation for Parkinson's Disease.
PMID 41992934 Published: 2026-04-17 Ingested: 2026-04-28 08:58 PM Annals of neurology
AI 55.0
Base 30.8
Rank 29.2
AI Summary

The authors developed and validated a multimodal, imaging-informed model that integrates contact coordinates, electric fields, tract activations, and network data to predict motor improvement and reliably identify optimal or adjacent STN-DBS contacts across multiple cohorts.

Why It Matters

While not a molecular therapeutic, this clinically validated, multimodal imaging approach has clear translational value for personalizing and streamlining DBS programming, improving patient outcomes and efficiency in Parkinson's neuromodulation care and trials.

E
Digital Gait Biomarkers for Parkinson's Disease: Subject-Wise Validated Explainable AI Framework Using Vertical Ground Reaction Force Signals.
PMID 41899891 Published: 2026-03-19 Ingested: 2026-04-28 08:58 PM Bioengineering (Basel, Switzerland)
AI 55.0
Base 30.8
Rank 29.2
AI Summary

This study presents a reproducible, explainable two-stage AI framework using vertical ground reaction force signals to both detect Parkinson's disease (AUC ≥ 0.93) and predict continuous H&Y severity (Spearman ρ = 0.921), and reports gait changes detectable up to ~4 years before diagnosis in a…

Why It Matters

Delivers a clinically relevant, wearable-compatible digital biomarker and interpretable pipeline for early screening and longitudinal monitoring of PD that can improve patient stratification and trial endpoints, though it does not expose molecular therapeutic targets.

E
StimVision: smartphone video kinematics to optimize DBS programming in Parkinson's disease.
PMID 42009683 Published: 2026-04-20 Ingested: 2026-04-28 08:58 PM NPJ Parkinson's disease
AI 52.0
Base 30.8
Rank 29.2
AI Summary

This study presents StimVision, a smartphone video-based, markerless kinematic pipeline that quantifies hand movement features to objectively rank and optimize DBS programming within sessions in Parkinson’s patients.

Why It Matters

By providing scalable, quantitative motor biomarkers and a patient-specific improvement score, the method can make DBS programming more efficient and reproducible, enable comparative assessment against dopaminergic therapy, and facilitate objective endpoints for clinical optimization and trials.

E
Five-Year Follow-Up of Unilateral Focused Ultrasound Subthalamotomy for Parkinson's Disease.
PMID 41987484 Published: 2026-04-15 Ingested: 2026-04-28 08:58 PM Movement disorders : official journal of the Movement Disorder Society
AI 52.0
Base 30.8
Rank 29.2
AI Summary

Prospective open-label study (n=45, 32 at 5 years) showing unilateral focused‑ultrasound subthalamotomy gives sustained, side-specific motor improvement (54% off‑med MDS‑UPDRS‑III improvement for treated side; overall 27% reduction) with increased LEDD, stable QoL/function, and no late adverse…

Why It Matters

Demonstrates durable, noninvasive, clinically actionable symptomatic benefit of STN‑FUS as a long‑term alternative to invasive neurosurgical approaches, informing therapeutic strategy and device development despite lacking disease‑modifying mechanistic insight.

E
Transient Interactions of α-Synuclein N- and C-Termini.
PMID 41911551 Published: 2026-04-15 Ingested: 2026-04-28 08:58 PM ACS chemical neuroscience
AI 52.0
Base 30.8
Rank 29.2
AI Summary

Using PICUP and targeted tyrosine mutations, the study maps transient intra- and inter-molecular contacts of α‑synuclein across solution, membrane-bound, oligomeric and fibrillar states, finding that membrane binding disrupts N–C intramolecular contacts while C‑terminal intermonomer contacts…

Why It Matters

By defining state-specific α‑synuclein contact interfaces—especially persistent C‑terminal intermonomer interactions—this work clarifies mechanistic steps of aggregation, highlights a plausible target region for interventions or biomarker development, and provides a robust protocol useful for…

E
In vivo classification of neuropathological disease stages in Parkinson's disease by diffusion tensor imaging.
PMID 42031082 Published: 2026-04-22 Ingested: 2026-04-28 08:58 PM NeuroImage
AI 50.0
Base 30.8
Rank 29.2
AI Summary

Using a tract-of-interest DTI/TFAS approach on 206 scans, the study detected stage-correlated fractional anisotropy reductions in white-matter tracts mapped to the six neuropathological stages of PD and used these patterns to classify in vivo disease-stage progression.

Why It Matters

Offers a noninvasive MRI-based framework to stage and track PD-related neurodegeneration that could be used as a surrogate biomarker for patient stratification and outcome measurement in therapeutic trials, though it does not address molecular mechanisms or interventions.

E
Diffusion Magnetic Resonance Imaging of Cortical Microstructure Differs in Nonmanifest and Manifest Genetic Parkinson's Disease.
PMID 41978242 Published: 2026-04-13 Ingested: 2026-04-28 08:58 PM Movement disorders : official journal of the Movement Disorder Society
AI 50.0
Base 30.8
Rank 29.2
AI Summary

This diffusion MRI study found progressive reductions in cortical parallel diffusivity (ParlPD) from nonmanifest to manifest genetic PD, with more pronounced cortical microstructural alterations in GBA1 versus LRRK2 carriers.

Why It Matters

Identifies a noninvasive microstructural imaging biomarker useful for early detection, staging, and stratifying genetic PD cohorts (particularly GBA1) for trials and progression monitoring, offering translational value despite limited mechanistic or therapeutic insights.

E
Precise disease heterogeneity and progression quantification in MSA and Parkinson's disease using machine learning.
PMID 41912595 Published: 2026-03-30 Ingested: 2026-04-28 08:58 PM Scientific reports
AI 50.0
Base 30.8
Rank 29.2
AI Summary

The study presents a machine-learning pipeline that produces a patient-specific heterogeneity score (HET) from multimodal MRI with SHAP explainability, distinguishing MSA subtypes from PD, identifying key affected regions (olivopontocerebellar and striatonigral areas and widespread white matter),…

Why It Matters

Delivers a quantitative, explainable imaging biomarker useful for diagnosis, patient stratification, and sensitive longitudinal monitoring—tools that can improve clinical trial selection and outcome measurement and thereby indirectly accelerate therapeutic development despite not revealing…

E
Striatal DAT and disease progression in Parkinson's disease: New evidence from autonomic dysfunction.
PMID 41905337 Published: 2026-03-24 Ingested: 2026-04-28 08:58 PM Parkinsonism & related disorders
AI 50.0
Base 30.8
Rank 29.2
AI Summary

In a 5-year longitudinal study of 1,219 early PD patients, higher striatal DAT uptake on DAT-SPECT was associated with slower progression of autonomic dysfunction.

Why It Matters

Supports striatal DAT availability as a prognostic biomarker for autonomic decline that can aid patient stratification and trial design, though it offers limited direct insight into therapeutic mechanisms or targets.

AI Summary

Quantitative susceptibility mapping found increased dentate nucleus iron deposition in tremor-dominant PD versus PIGD and controls, with DN susceptibility correlating with tremor severity and, combined with levodopa dose, distinguishing subtypes (AUC 0.898).

Why It Matters

Provides a noninvasive imaging biomarker tied to tremor-related CTC circuit pathology and iron dysregulation that could help stratify patients for subtype-specific trials and suggest exploration of iron-modulating therapies.

E
Continuous observation of Parkinsonian symptoms using symptom diaries & wearable accelerometry.
PMID 41957027 Published: 2026-04-09 Ingested: 2026-04-28 08:58 PM Scientific data
AI 48.0
Base 30.8
Rank 29.2
AI Summary

Open dataset of simultaneous bilateral wrist accelerometry and patient symptom diaries from 66 Parkinson's patients (≈394 total days) enabling development and validation of wearable-based motor symptom monitoring.

Why It Matters

Provides a real-world, labelled dataset to develop objective, continuous digital biomarkers and remote monitoring endpoints that can improve assessment of motor fluctuations and support clinical trial measurements, though it does not address underlying disease mechanisms or novel therapeutics.

E
Subregional thalamic atrophy in Progressive Supranuclear Palsy: A machine learning study.
PMID 41962171 Published: 2026-04-03 Ingested: 2026-04-28 08:58 PM NeuroImage. Clinical
AI 48.0
Base 30.8
Rank 29.2
AI Summary

Using automated FreeSurfer subnuclear segmentation and XGBoost on two independent cohorts, the study found marked atrophy in lateral, paraventricular, and pulvinar thalamic nuclei in PSP and achieved AUC 0.96 for distinguishing PSP from PD based on thalamic nuclei volumes.

Why It Matters

Identifies a robust, translatable MRI-based subregional thalamic volumetric biomarker that can improve differential diagnosis and trial cohort selection for PSP (and thereby indirectly aid therapeutic development), though it offers limited direct mechanistic or targetable insights for Parkinson's…

E
Limbic free-water alterations as neuroimaging biomarkers for predicting phenoconversion in prodromal Parkinson's disease.
PMID 42013782 Published: 2026-03-27 Ingested: 2026-04-28 08:58 PM Parkinsonism & related disorders
AI 48.0
Base 30.8
Rank 29.2
AI Summary

This study finds that elevated free-water in limbic regions (notably the left insula and mid-cingulate, plus hippocampus and right orbitofrontal cortex) combined with RBD and anxiety scores predicts conversion from prodromal to clinical Parkinson's disease with a combined-model AUC ~0.76.

Why It Matters

Provides a noninvasive, translatable biomarker signature that could be used to enrich and stratify prodromal PD cohorts for early intervention trials and longitudinal therapeutic evaluation, though it does not yet reveal targetable disease mechanisms.

E
Pallidal and subthalamic stimulations modulate inter-hemispheric interaction and asymmetry in Parkinson's disease.
PMID 41904270 Published: 2026-03-29 Ingested: 2026-04-28 08:58 PM Molecular psychiatry
AI 46.0
Base 30.8
Rank 29.2
AI Summary

Resting-state fMRI and UPDRS-III data from 55 PD patients show that bilateral STN- and GPi-DBS both improve motor symptoms but differentially reduce motor asymmetry depending on baseline laterality, with motor gains linked to altered homotopic connectivity in the lateral occipital/extrastriate body…

Why It Matters

Provides clinically actionable insight for DBS target selection and a candidate imaging biomarker in visual networks that may help predict and optimize motor outcomes, offering moderate translational value though not addressing disease-modifying mechanisms.

E
Motoneuron Excitability in Parkinson's Disease: Effects of Dopaminergic Medication.
PMID 42003164 Published: 2026-04-19 Ingested: 2026-04-28 08:58 PM Journal of neurophysiology
AI 45.0
Base 30.8
Rank 29.2
AI Summary

This human study found elevated motoneuron excitability and PIC-related amplification in people with Parkinson's disease compared with age-matched controls, and that dopaminergic medication did not fully normalize these measures.

Why It Matters

By implicating persistent intrinsic motoneuron changes and PICs that are insensitive to dopamine replacement, the work points to non-dopaminergic targets (ion channels, alternate monoaminergic systems) and electrophysiologic biomarkers that could be exploited for therapeutic discovery.

E
Geo-Mamba: Geometry-informed state-space learning of functional brain organization.
PMID 41997086 Published: 2026-04-12 Ingested: 2026-04-28 08:58 PM Medical image analysis
AI 45.0
Base 30.8
Rank 29.2
AI Summary

Geo-Mamba is a geometry-informed dual-path state-space model that operates on Riemannian manifolds of fMRI/EEG functional connectivity to produce compact SPD representations and improves classification robustness across multiple neuroimaging datasets, including three Parkinson's cohorts.

Why It Matters

Although it does not address molecular mechanisms or interventions, the method has moderate translational value by potentially improving PD biomarker detection, patient stratification, and cross-modal neuroimaging analyses for clinical studies and trial endpoints.

E
Classification of functional brain patterns elicited by deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
PMID 41955135 Published: 2026-04-09 Ingested: 2026-04-28 08:58 PM IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
AI 45.0
Base 30.8
Rank 29.2
AI Summary

Using resting-state fMRI from 104 PD patients (plus 34 external validation), the study applied nine machine-learning algorithms to classify subthalamic nucleus DBS ON vs OFF and found that global connectivity metrics with linear models or nonlinear SVMs achieved up to AUC 0.82, supporting…

Why It Matters

Identifies validated fMRI-derived features and analytic approaches that could become objective biomarkers to standardize and personalize DBS programming and to track network-level effects relevant for therapeutic optimization in Parkinson's disease.

Previous
Page 25 of 61
Next
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic
Full Neurocompute Infographic